Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial
PaperCitations, authors & open-access status
Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 301 citations, 2015 year and green oa status.
301
Citations
2015
Year
green
OA Status